These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6999003)

  • 1. Hormonal and metabolic studies in a patient with a pheochromocytoma.
    Turnbull DM; Johnston DG; Alberti KG; Hall R
    J Clin Endocrinol Metab; 1980 Oct; 51(4):930-3. PubMed ID: 6999003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of pharmacological adrenergic blockade in phaeochromocytoma.
    Krentz AJ; Hale PJ; Horrocks PM; Heslop KE; Johnston DG; Wright AD; Nattrass M
    Clin Endocrinol (Oxf); 1991 Feb; 34(2):139-45. PubMed ID: 2022064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and metabolic studies in pheochromocytoma.
    Calandra RS; Antar MA; Plautz M; Little JA; Martin JM; Johnson GE
    Can Med Assoc J; 1970 Jun; 102(13):1369-72. PubMed ID: 5422431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptors desensitization may modulate catecholamine induced insulin resistance in human pheochromocytoma.
    di Paolo S; de Pergola G; Cospite MR; Guastamacchia E; Cignarelli M; Balice A; Cospite MR; Nardelli GM; Giorgino R
    Diabete Metab; 1989; 15(6):409-15. PubMed ID: 2560726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities in obese patients with impaired glucose tolerance.
    Robertson DA; Singh BM; Baddeley RM; Nattrass M
    Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonesterified fatty acids and glucose in lactating dairy cows: diurnal variations and changes in responsiveness during fasting to epinephrine and effects of beta-adrenergic blockade.
    Fröhli DM; Blum JW
    J Dairy Sci; 1988 May; 71(5):1170-7. PubMed ID: 3294257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M; Khalfallah Y; Riou JP; Cohen R; Normand S; Mornex R
    J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and metabolic changes in hepatic cirrhosis.
    Johnston DG; Alberti KG; Binder C; Faber OK; Wright R; Orskov H
    Horm Metab Res; 1982 Jan; 14(1):34-9. PubMed ID: 7037586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
    Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
    Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
    Krentz AJ; Coles NH; Williams AC; Nattrass M
    Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of catecholamines in the ketonemic response to somatostatin in normal man.
    Beaufrere B; Beylot M; Riou JP; Serusclat P; Cohen R; Souquet JC; Mornex R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):847-50. PubMed ID: 6136524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered insulin response to glucose in weight-losing cancer patients.
    Rofe AM; Bourgeois CS; Coyle P; Taylor A; Abdi EA
    Anticancer Res; 1994; 14(2B):647-50. PubMed ID: 8010722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma insulin levels in endocrine diseases. 3. Plasma insulin levels in patients with adrenal gland diseases and during steroid treatment].
    Ikeda M
    Nihon Naibunpi Gakkai Zasshi; 1973 Oct; 49(10):1286-96. PubMed ID: 4797058
    [No Abstract]   [Full Text] [Related]  

  • 18. Splanchnic and renal exchange of infused fructose in insulin-deficient type 1 diabetic patients and healthy controls.
    Björkman O; Gunnarsson R; Hagström E; Felig P; Wahren J
    J Clin Invest; 1989 Jan; 83(1):52-9. PubMed ID: 2910919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin, and human chorionic somatomammotropin during the last trimester.
    Persson B; Lunell NO
    Am J Obstet Gynecol; 1975 Jul; 122(6):737-45. PubMed ID: 1155514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.